Renamed Cardiovascular Solutions in 2011, the original Medeikon Corporation was led through start-up by a seasoned management team having experience in optics, electronics and signal processing, and expertise in medicine, biomedical engineering and medical imaging technology. The firm was organized around development of a photonics-based interventional cardiology diagnostic instrument. The firm took the project through development and execution of pre-clinical validation protocols, data collection and analysis and built a well cited patent portfolio.